We use essential cookies for the site to work and optional analytics and marketing cookies. You can accept or reject them — your choice can be changed at any time. Learn more
Articles on health, nutrition and wellness for GLP-1 users
Entenda como a entrada de fabricantes nacionais de canetas GLP-1 mudou o cenário de prescrição, acesso e custos no tratamento da obesidade no Brasil.
Brazilian pharmacies are tightening their monitoring of GLP-1 weight loss medications. Understand what this means for patients and how to navigate the changing prescription landscape in Brazil.
Follow your health journey
Log meals, track your weight and follow your progress with OzemPro. All in one place, simple and intuitive.
Build my plan
GLP-1 pens can stop producing results for several reasons beyond simple non-response. Here's what clinical evidence says about identifying when a switch is needed versus when more time is the answer.
The molecule inside a GLP-1 pen works the same way whether you have type 2 diabetes or want to lose weight. But dosing, monitoring, and insurance coverage can differ significantly.
Comparing the tolerability profiles of Mounjaro, Wegovy, and Ozempic based on clinical trial data and safety records. Learn what the evidence says about GI side effects, injection reactions, and rare risks.
The so-called "Ozempic runway" trend reveals uncomfortable truths about how the fashion industry, pharmaceutical culture, and body ideals have become intertwined. Here's what it all means.
Not all semaglutide products are the same. Understanding the differences between originator, generic, and how these medications are manufactured can help you make more informed decisions about your treatment.
Health authorities worldwide are increasingly concerned about the illegal trade of tirzepatide products from Paraguay. Here's what patients need to know about the risks and safer alternatives.
GLP-1 weight loss pens are frequent counterfeiting targets. Learn practical ways to verify authenticity and protect your health before using any suspicious product.
A data-driven look at why GLP-1 medications can cause temporary hair shedding, who is most at risk, and what recovery actually looks like.
